ARTICLE | Distillery Therapeutics
Cancer
August 9, 2017 6:42 PM UTC
Cell culture and mouse studies suggest inhibiting CDCP1 could help treat metastatic triple-negative breast cancer (TNBC). In three human TNBC cell lines, CDCP1 knockdown increased numbers of cytoplasm...
BCIQ Company Profiles
BCIQ Target Profiles